StemCells, Inc. Anno
StemCells, Inc. Announces Strategic Realignment
December 23, 2015 08:05 ET | StemCells, Inc.
NEWARK, Calif., Dec. 23, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the...
StemCells, Inc. Inte
StemCells, Inc. Interim Trial Data Show Motor Improvement in Patients With Cervical Spinal Cord Injury
November 18, 2015 16:05 ET | StemCells, Inc.
NEWARK, Calif., Nov. 18, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the...
StemCells, Inc. Anno
StemCells, Inc. Announces Webcast to Discuss Interim Results From the First Cohort in Its Phase II Study in Cervical Spinal Cord Injury
November 12, 2015 08:05 ET | StemCells, Inc.
NEWARK, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the...
StemCells, Inc. Repo
StemCells, Inc. Reports Third Quarter 2015 Financial Results
November 02, 2015 16:05 ET | StemCells, Inc.
Company to Host Call to Provide Interim Results from the First Cohort in its Phase II Pathway™ Study in Cervical Spinal Cord Injury NEWARK, Calif., Nov. 02, 2015 (GLOBE NEWSWIRE) --...
StemCells, Inc. to P
StemCells, Inc. to Participate at the Rodman & Renshaw 17th Annual Global Investment Conference
August 26, 2015 08:05 ET | StemCells, Inc.
NEWARK, Calif., Aug. 26, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will make a presentation on the Company's programs, pipeline and operations at the...
StemCells, Inc. Repo
StemCells, Inc. Reports Second Quarter 2015 Financial Results, Business Update and Clinical Program Highlights
August 06, 2015 16:05 ET | StemCells, Inc.
NEWARK, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the central...
Court Rules That Ste
Court Rules That StemCells, Inc. Lacks Standing to Pursue Patent Infringement Suit
July 23, 2015 13:42 ET | StemCells, Inc.
NEWARK, Calif., July 23, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the central...
StemCells, Inc. Anno
StemCells, Inc. Announces Webcast to Discuss Second Quarter 2015 Financial Results
July 22, 2015 08:05 ET | StemCells, Inc.
NEWARK, Calf., July 22, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Tran
StemCells, Inc. Transplants First Patient in Phase II Clinical Trial for Dry Age-Related Macular Degeneration
July 20, 2015 08:05 ET | StemCells, Inc.
NEWARK, Calif., July 20, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the brain,...
StemCells, Inc. Clin
StemCells, Inc. Clinical Programs Overview and Progress Update
July 09, 2015 17:45 ET | StemCells, Inc.
NEWARK, Calif., July 9, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), in cooperation with the International Society for Stem Cell Research (ISSCR), has posted a video of the presentation...